Liver tumor induction in B6C3F1 mice by dichloroacetate and trichloroacetate
- PMID: 2219130
- DOI: 10.1016/0300-483x(90)90195-m
Liver tumor induction in B6C3F1 mice by dichloroacetate and trichloroacetate
Abstract
Male and female B6C3F1 mice were administered dichloroacetate (DCA) and trichloroacetate (TCA) in their drinking water at concentrations of 1 or 2 g/l for up to 52 weeks. Both compounds induced hepatoproliferative lesions (HPL) in male mice, including hepatocellular nodules, adenomas and hepatocellular carcinomas within 12 months. The induction of HPL by TCA was linear with dose. In contrast, the response to DCA increased sharply with the increase in concentration from 1 to 2 g/l. Suspension of DCA treatment at 37 weeks resulted in the same number of HPL at 52 weeks that would have been predicted on the basis of the total dose administered. However, none of the lesions in this treatment group progressed to hepatocellular carcinomas. Conversely, the yield of HPL at 52 weeks when TCA treatment was suspended at 37 weeks was significantly below that which would have been predicted by the total dose administered. In this case, 3 of 5 remaining lesions were hepatocellular carcinomas. Throughout active treatment DCA-treated mice displayed greatly enlarged livers characterized by a marked cytomegaly and massive accumulations of glycogen in hepatocytes throughout the liver. Areas of focal necrosis were seen throughout the liver. TCA produced small increases in cell size and much a more modest accumulation of glycogen. Focal necrotic damage did not occur in TCA-treated animals. TCA produced marked accumulations of lipofuscin in the liver. Lipofuscin accumulation was less marked with DCA. These data confirm earlier observations that DCA and TCA are capable of inducing hepatic tumors in B6C3F1 mice and argue that the mechanisms involved in tumor induction differ substantially between these two similar compounds. Tumorigenesis by DCA may depend largely on stimulation of cell division secondary to hepatotoxic damage. On the other hand, TCA appears to increase lipid peroxidation, suggesting that production of radicals may be responsible for its effects.
Similar articles
-
Interactions in the tumor-promoting activity of carbon tetrachloride, trichloroacetate, and dichloroacetate in the liver of male B6C3F1 mice.Toxicology. 2004 Jul 1;199(2-3):169-83. doi: 10.1016/j.tox.2004.02.018. Toxicology. 2004. PMID: 15147791
-
Differences in phenotype and cell replicative behavior of hepatic tumors induced by dichloroacetate (DCA) and trichloroacetate (TCA).Toxicol Appl Pharmacol. 1997 Jun;144(2):235-46. doi: 10.1006/taap.1997.8159. Toxicol Appl Pharmacol. 1997. PMID: 9194407
-
The role of dichloroacetate in the hepatocarcinogenicity of trichloroethylene.Toxicol Lett. 1993 May;68(1-2):203-11. doi: 10.1016/0378-4274(93)90131-g. Toxicol Lett. 1993. PMID: 8516764
-
Mode of action of liver tumor induction by trichloroethylene and its metabolites, trichloroacetate and dichloroacetate.Environ Health Perspect. 2000 May;108 Suppl 2(Suppl 2):241-59. doi: 10.1289/ehp.00108s2241. Environ Health Perspect. 2000. PMID: 10807555 Free PMC article. Review.
-
Evaluation of the role of peroxisome proliferator-activated receptor alpha (PPARalpha) in mouse liver tumor induction by trichloroethylene and metabolites.Crit Rev Toxicol. 2008;38(10):857-75. doi: 10.1080/10408440802209796. Crit Rev Toxicol. 2008. PMID: 18821149 Review.
Cited by
-
The induction of tumor necrosis factor-alpha, superoxide anion, myeloperoxidase, and superoxide dismutase in the peritoneal lavage cells of mice after prolonged exposure to dichloroacetate and trichloroacetate.J Biochem Mol Toxicol. 2010 Mar-Apr;24(2):136-44. doi: 10.1002/jbt.20322. J Biochem Mol Toxicol. 2010. PMID: 20391627 Free PMC article.
-
Dichloroacetate for Cancer Treatment: Some Facts and Many Doubts.Pharmaceuticals (Basel). 2024 Jun 6;17(6):744. doi: 10.3390/ph17060744. Pharmaceuticals (Basel). 2024. PMID: 38931411 Free PMC article. Review.
-
Bioenergetic alteration in gastrointestinal cancers: The good, the bad and the ugly.World J Gastroenterol. 2023 Aug 7;29(29):4499-4527. doi: 10.3748/wjg.v29.i29.4499. World J Gastroenterol. 2023. PMID: 37621758 Free PMC article. Review.
-
PBPK modeling of impact of nonalcoholic fatty liver disease on toxicokinetics of perchloroethylene in mice.Toxicol Appl Pharmacol. 2020 Aug 1;400:115069. doi: 10.1016/j.taap.2020.115069. Epub 2020 May 21. Toxicol Appl Pharmacol. 2020. PMID: 32445755 Free PMC article.
-
Biological Basis of Differential Susceptibility to Hepatocarcinogenesis among Mouse Strains.J Toxicol Pathol. 2009 Mar;22(1):11-33. doi: 10.1293/tox.22.11. Epub 2009 Apr 6. J Toxicol Pathol. 2009. PMID: 22271974 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials